139 related articles for article (PubMed ID: 8050082)
21. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
Patel PS; Baxi BR; Adhvaryu SG; Balar DB
Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
[TBL] [Abstract][Full Text] [Related]
23. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Andersen JW
Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
[TBL] [Abstract][Full Text] [Related]
25. The significance of serum lipid-bound sialic acid in bladder tumours.
Oztokatli A; Ozkardeş H; Ovül E; Erol D
Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic value of biochemical tumor markers in brain tumors. Review of the literature and own experience with serum analysis of sialic acid (NANA), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE)].
Flaschka G; Marth E; Desoye G; Freidl W; Walzl M
Zentralbl Neurochir; 1990; 51(3):129-37. PubMed ID: 2092546
[TBL] [Abstract][Full Text] [Related]
27. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
28. Serum beta-N-acetylhexosaminidase, carcinoembryonic antigen & sialic acid in benign & malignant extrahepatic biliary obstruction.
Saha NK; Khanduja KL; Bose SM
Indian J Med Res; 1993 Dec; 98():269-73. PubMed ID: 8132228
[TBL] [Abstract][Full Text] [Related]
29. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
[TBL] [Abstract][Full Text] [Related]
30. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
Polívková J; Vosmiková K; Pospísil J; Poucková P
Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
[TBL] [Abstract][Full Text] [Related]
31. Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer.
Erbil KM; Jones JD; Klee GG
Cancer; 1985 Jan; 55(2):404-9. PubMed ID: 3965096
[TBL] [Abstract][Full Text] [Related]
32. Serum total sialic acid and regan isoenzyme levels in patients with lung cancer.
Patel PS; Baxi BR; Desai SS; Balar DB
Indian J Pathol Microbiol; 1990 Apr; 33(2):124-8. PubMed ID: 2391142
[TBL] [Abstract][Full Text] [Related]
33. Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer.
Bergman B; Brezicka FT; Engström CP; Larsson S
Eur J Cancer; 1993; 29A(2):198-202. PubMed ID: 8380696
[TBL] [Abstract][Full Text] [Related]
34. Axillary versus peripheral blood levels of sialic acid, ferritin, and CEA in patients with breast cancer.
Monti M; Catania S; Locatelli E; Gandini R; Reggiani A; Cunietti E
Breast Cancer Res Treat; 1990 Dec; 17(2):77-82. PubMed ID: 2096995
[TBL] [Abstract][Full Text] [Related]
35. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
Lee YC; Yang PC; Kuo SH; Luh KT
J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
[TBL] [Abstract][Full Text] [Related]
36. Combined measurement and significance of lipid-bound sialic acid and carcinoembryonic antigen in detection of human cancer.
Munjal DD; Picken J; Pritchard J
Diagn Immunol; 1984; 2(1):36-43. PubMed ID: 6499373
[TBL] [Abstract][Full Text] [Related]
37. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.
Lagana A; Martinez BP; Marino A; Fago G; Bizzarri M
Anticancer Res; 1995; 15(5B):2341-6. PubMed ID: 8572649
[TBL] [Abstract][Full Text] [Related]
38. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
[TBL] [Abstract][Full Text] [Related]
39. Tumor markers in the blood of preoperative digestive cancer patients.
Bojan O; Bara A; Daicoviciu D; Bologa S; Duca S
Int J Biol Markers; 1993; 8(4):244-5. PubMed ID: 8138664
[No Abstract] [Full Text] [Related]
40. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
